Results 181 to 190 of about 4,690 (200)

Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study

Lancet Respiratory Medicine,the, 2021
Damian G Downey, Manu Jain, David J Pasta   +2 more
exaly  

Reversal of cystic bronchiectasis with elexacaftor/tezacaftor/ivacaftor

European Respiratory Journal
Peter G. Middleton, Nicholas J. Simmonds
openaire   +2 more sources

Elexacaftor/tezacaftor/ivacaftor can rescue pancreatic function in F508del homozygous children

Pediatric Pulmonology, 2023
Nathan, Nadia, Thouvenin, Guillaume, Dubern, Béatrice, Corvol, Harriet   +3 more
openaire   +2 more sources

Elexacaftor‐tezacaftor‐ivacaftor overdose in an adolescent female with cystic fibrosis

Pediatric Pulmonology, 2022
Benjamin C. Lyman, Jessica Seay, Casey Contreary, Adrienne P. Savant, Mary Lynn Dell, George C. Hescock   +5 more
openaire   +2 more sources

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Lancet, The, 2019
Edward F Mckone, Damian G Downey, Eva Van Braeckel   +2 more
exaly  

Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del

New England Journal of Medicine, 2017
Anne Munck, Edward F Mckone, Cornelis K Van Der Ent   +2 more
exaly  

VX-659–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles

New England Journal of Medicine, 2018
Marcus A Mall, Edward F Mckone, Dario Prais   +2 more
exaly  

Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis

New England Journal of Medicine, 2017
Felix C C Ringshausen, John Wilson, Elizabeth Tullis   +2 more
exaly  

VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles

New England Journal of Medicine, 2018
Lucy Burr, Marcus A Mall, Edward F Mckone   +2 more
exaly  

Elexacaftor/tezacaftor/ivacaftor

Reactions Weekly
openaire   +1 more source